Bio-Techne’s Ella platform has secured CE-IVD marking, enabling its sale and use in the EU for precision diagnostics. This platform provides rapid, accurate biomarker results in under 90 minutes, supporting clinical decision-making and compatible with over 390 analytes across neuroscience, immunology, and oncology. The certification reinforces Bio-Techne’s commitment to advancing precision medicine through reliable and standardized biomarker detection solutions.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Bio-Techne's Ella Platform Receives CE-IVD Marking
Bio-Techne’s Ella platform has secured CE-IVD marking, enabling its sale and use in the EU for precision diagnostics. This platform provides rapid, accurate biomarker results in under 90 minutes, supporting clinical decision-making and compatible with over 390 analytes across neuroscience, immunology, and oncology. The certification reinforces Bio-Techne’s commitment to advancing precision medicine through reliable and standardized biomarker detection solutions.